Surgalign Holdings, Inc. (SRGA): Price and Financial Metrics


Surgalign Holdings, Inc. (SRGA): $2.20

-0.03 (-1.35%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

SRGA POWR Grades

  • SRGA scores best on the Value dimension, with a Value rank ahead of 76.15% of US stocks.
  • SRGA's strongest trending metric is Growth; it's been moving down over the last 112 days.
  • SRGA ranks lowest in Quality; there it ranks in the 17th percentile.

SRGA Stock Summary

  • With a one year PEG ratio of 0.45, SURGALIGN HOLDINGS INC is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than only 4.34% of US stocks.
  • SRGA's price/sales ratio is 0.19; that's higher than the P/S ratio of merely 5.07% of US stocks.
  • In terms of volatility of its share price, SRGA is more volatile than 96.68% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to SURGALIGN HOLDINGS INC are XRX, DRTT, AYTU, TRVG, and HAS.
  • Visit SRGA's SEC page to see the company's official filings. To visit the company's web site, go to www.rtix.com.

SRGA Valuation Summary

  • SRGA's price/earnings ratio is -0.3; this is 101.29% lower than that of the median Healthcare stock.
  • SRGA's EV/EBIT ratio has moved up 8.1 over the prior 243 months.

Below are key valuation metrics over time for SRGA.

Stock Date P/S P/B P/E EV/EBIT
SRGA 2022-11-25 0.2 1.4 -0.3 -0.2
SRGA 2022-11-23 0.2 1.3 -0.3 -0.2
SRGA 2022-11-22 0.2 1.2 -0.2 -0.2
SRGA 2022-11-21 0.2 1.2 -0.3 -0.2
SRGA 2022-11-18 0.2 1.2 -0.3 -0.2
SRGA 2022-11-17 0.2 1.3 -0.3 -0.2

SRGA Growth Metrics

    Its 5 year net income to common stockholders growth rate is now at -1130.9%.
  • Its year over year cash and equivalents growth rate is now at -29.93%.
  • The 5 year revenue growth rate now stands at 14.48%.
SRGA's revenue has moved down $19,002,000 over the prior 15 months.

The table below shows SRGA's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 83.236 -55.969 -60.856
2022-06-30 83.603 -38.054 -58.929
2022-03-31 87.814 -56.404 -69.433
2021-12-31 90.5 -51.792 -84.651
2021-09-30 94.857 -56.98 -139.329
2021-06-30 102.238 -119.596 -8.739

SRGA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • SRGA has a Quality Grade of C, ranking ahead of 26.03% of graded US stocks.
  • SRGA's asset turnover comes in at 0.676 -- ranking 55th of 186 Medical Equipment stocks.
  • AHPI, HSDT, and RMD are the stocks whose asset turnover ratios are most correlated with SRGA.

The table below shows SRGA's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.676 0.618 -0.273
2021-03-31 0.686 0.522 -0.460
2020-12-31 0.420 0.568 -0.362
2020-09-30 0.794 0.536 -0.710
2020-06-30 0.707 0.535 -0.912
2020-03-31 0.658 0.556 -0.604

SRGA Price Target

For more insight on analysts targets of SRGA, see our SRGA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $3.36 Average Broker Recommendation 1.43 (Moderate Buy)

SRGA Stock Price Chart Interactive Chart >

Price chart for SRGA

SRGA Price/Volume Stats

Current price $2.20 52-week high $32.40
Prev. close $2.23 52-week low $1.53
Day low $2.18 Volume 51,100
Day high $2.45 Avg. volume 88,870
50-day MA $2.87 Dividend yield N/A
200-day MA $5.02 Market Cap 14.86M

Surgalign Holdings, Inc. (SRGA) Company Bio


Surgalign Holdings, Inc. operates as a holding company. The Company, through its subsidiaries, provides medical technology solutions with focus on spine surgery and elevating clinical outcomes. Surgalign Holdings serves customers worldwide.


SRGA Latest News Stream


Event/Time News Detail
Loading, please wait...

SRGA Latest Social Stream


Loading social stream, please wait...

View Full SRGA Social Stream

Latest SRGA News From Around the Web

Below are the latest news stories about SURGALIGN HOLDINGS INC that investors may wish to consider to help them evaluate SRGA as an investment opportunity.

Surgalign Announces Closing of $12.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

DEERFIELD, Ill., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced that the closing of its previously announced registered direct offering priced at the market under Nasdaq rules of 6,000,000 shares of the Company's common stock (or pre-funded warrants in lieu thereof) and Series A warrants to purchase up to 6,000,000 shares of common

Yahoo | November 16, 2022

Surgalign Announces $12.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

DEERFIELD, Ill., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced that it has entered into a definitive agreement with a single institutional investor for the sale and issuance of 6,000,000 shares of the Company's common stock (or pre-funded warrants in lieu thereof) and Series A warrants to purchase up to 6,000,000 shares of common

Yahoo | November 14, 2022

Surgalign™ Announces Corporate Restructuring Program to Focus on Key Growth Areas

Company plans to realign in an effort to improve efficiencies, while lowering its capital requirements to invest in innovation; estimated cash savings in 2023 are expected to be approximately $30 - $35 millionDEERFIELD, Ill., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that its Board of Directors has approved a corporate restruct

Yahoo | November 9, 2022

Surgalign Announces Third Quarter 2022 Results and Provides Update on Business Operations and Financial Outlook

DEERFIELD, Ill., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced financial results for its 2022 third quarter ended September 30, 2022. 2022 Third Quarter Corporate Highlights: Two new clinical sites in Ohio utilize the HOLO PortalTM surgical guidance system.FDA 510(k) clearance of the Cortera™ Spinal Fixation System, the first orga

Yahoo | November 2, 2022

Surgalign Schedules Third Quarter 2022 Earnings Release for November 2, 2022

DEERFIELD, Ill., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced its plans to release financial results for its third quarter ended September 30, 2022 after the close of trading on November 2, 2022. Surgalign will host a conference call and audio webcast at 4:30 p.m. ET the same day. The conference call can be accessed by dialing (86

Yahoo | October 25, 2022

Read More 'SRGA' Stories Here

SRGA Price Returns

1-mo 21.55%
3-mo N/A
6-mo -52.79%
1-year -89.90%
3-year -96.10%
5-year -98.37%
YTD -89.76%
2021 -67.29%
2020 -20.07%
2019 -25.95%
2018 -9.76%
2017 26.15%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5637 seconds.